Mobile

donwloadimg

Desktop

View more versions

English
中文繁體
中文简体

Markets
Products
News
Moo Community
- Feed
  
  Find inspiration for your next move
- Topics
  
  Discuss hot topics with like-minded traders
Learn
Investing
- Investment Choices
  
  Explore investment products
  Cash Sweep
  
  Stocks
  
  Fractional Shares
  
  ETFs
  
  Options
  
  Margin Trade
- Features
  
  See our powerful trading features in action
  Charts
  
  Stock Analysis
  
  Level 2 Data
  
  Nasdaq Market Depth
- Pricing
  
  Transparent fees, no account minimums

Log in

Open Account

Financial services in the moomoo app are provided by Moomoo Financial Inc. You will be redirected to Moomoo Financial Inc's web domain, where the account application pages are hosted.

Sign up/Log in

Log Out

English

Light

Dark

Back

Markets
Products
News
Moo Community
- Feed
  
  Find inspiration for your next move
Learn
Investing
- Investment Choices
  - Cash Sweep
  - Stocks
  - Fractional Shares
  - ETFs
  - Options
  - Margin Trade
- Features
- Pricing
  
  Transparent fees, no account minimums

English
中文繁體
中文简体

Dark
Light

Log in to access Online Inquiry

Back to the Top

Watchlist
Paper Trade
Screener
Heat Map
Institutional
Tracker

US OptionsDetailed Quotes

ARKG240705P23000

Watchlist

0.03
0.000.00%

15min DelayClose Jul 5 15:38 ET

0.25High0.03Low

0.25Open0.03Pre Close3 Volume74 Open Interest23.00Strike Price0.00Turnover265.20%IV2.50%PremiumJul 5, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.1928Delta0.9778Gamma785.33Leverage Ratio-5.1178Theta0.0000Rho-151.45Eff Leverage0.0003Vega

Overview Options News Comments

ARK Genomic Revolution ETF Newsroom

News

Announcement

Ratings

Schrodinger Analyst Ratings
BenzingaJul 2 13:02 ET
Buy Rating for Arcturus Therapeutics: Advancing Clinical Programs and Strengthening Safety Profile
TipRanksJul 2 07:00 ET
Piper Sandler Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)
TipRanksJul 2 06:45 ET
Arcturus Therapeutics Analyst Ratings
BenzingaJul 2 06:27 ET
Buy Rating Affirmed: Promising Developments in Arcturus Therapeutics' MRNA Treatments for Rare Diseases
TipRanksJul 2 06:25 ET
Twist Bioscience Analyst Ratings
BenzingaJun 28 12:03 ET
Nurix Therapeutics Analyst Ratings
BenzingaJun 27 10:30 ET
Intellia Therapeutics Analyst Ratings
BenzingaJun 27 09:38 ET
Canaccord Genuity Maintains Buy on Intellia Therapeutics, Maintains $73 Price Target
BenzingaJun 27 09:38 ET
Ionis Pharmaceuticals Analyst Ratings
BenzingaJun 27 08:20 ET
CRISPR Therapeutics Analyst Ratings
BenzingaJun 27 05:35 ET
Recursion Pharmaceuticals Analyst Ratings
BenzingaJun 25 07:45 ET
Intellia Therapeutics Analyst Ratings
BenzingaJun 24 13:36 ET
Intellia Therapeutics Analyst Ratings
BenzingaJun 18 10:12 ET
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $26
BenzingaJun 18 06:10 ET
Nurix Therapeutics Analyst Ratings
BenzingaJun 17 05:50 ET
CRISPR Therapeutics Analyst Ratings
BenzingaJun 17 05:37 ET
Ionis Pharmaceuticals Analyst Ratings
BenzingaJun 14 05:55 ET
Twist Bioscience Analyst Ratings
BenzingaJun 13 12:42 ET
Nurix Therapeutics Analyst Ratings
BenzingaJun 5 10:07 ET

About moomoo

Terms & Conditions

Licensed Entities*

Your Privacy Choices

Careers / Contact:

hr@us.moomoo.com

The moomoo app is an online trading platform offered by Moomoo Technologies Inc. Securities, brokerage products and related services available through the moomoo app are offered by including but not limited to the following brokerage firms: Moomoo Financial Inc. regulated by the U.S. Securities and Exchange Commission (SEC), Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS), Futu Securities International (Hong Kong) Limited regulated by the Securities and Futures Commission of Hong Kong (SFC), Moomoo Financial Canada Inc. regulated by the Canadian Investment Regulatory Organization (CIRO) and Moomoo Securities Australia Ltd regulated by the Australian Securities and Investments Commission (ASIC).

For further information about Moomoo Financial Inc., please visit Financial Industry Regulatory Authority (FINRA)’s BrokerCheck. Brokerage accounts with Moomoo Financial Inc. are protected by the Securities Investor Protection Corporation (SIPC). Moomoo Financial Inc. is a member of Securities Investor Protection Corporation (SIPC), which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). It is important to understand that SIPC protects customer accounts against losses caused by the financial failure of the broker-dealer, but not against an increase or decrease in the market value of securities in customers' accounts. SIPC does not protect against market risk, which is the risk inherent in a fluctuating market. For further information about SIPC coverage for accounts with Moomoo Financial Inc., see www.sipc.org or request an explanatory brochure from Moomoo Financial Inc.

Options trading entails significant risk and is not appropriate for all customers. It is important that investors read Characteristics and Risks of Standardized Options before engaging in any options trading strategies. Options transactions are often complex and may involve the potential of losing the entire investment in a relatively short period of time. Certain complex options strategies carry additional risk, including the potential for losses that may exceed the original investment amount. Supporting documentation for any claims, if applicable, will be furnished upon request.

Investments in stocks, options, ETFs and other instruments are subject to risks, including possible loss of the amount invested. The value of investments may fluctuate and as a result, clients may lose the value of their investment. Past performance should not be viewed as an indicator of future results.

Margin trading involves interest charges and heightened risks, including the potential to lose more than invested funds or the need to deposit additional collateral. Before trading on margin, customers are advised to determine whether this type of trading is appropriate for them in light of their respective investment objective, experience, risk tolerance and financial situation.

Free trading refers to $0 commissions for Moomoo Financial Inc. self-directed individual cash or margin brokerage accounts of U.S. residents that trade U.S. listed securities via mobile devices or Web. Relevant SEC & FINRA fees may apply. For details, please see Commission and Fees.

All types of investments are risky and investors may suffer losses. Past performance of investment products does not guarantee future results. Electronic trading also poses risks to investors. The responsiveness of the trading system may vary due to market conditions, system performance, and other factors. Account access and trade execution may be affected by factors such as market volatility.

No content on the website shall be considered as a recommendation or solicitation for the purchase or sale of securities, futures, or other financial products. All information and data on the website are for reference only and no historical data shall be considered as the basis for predicting future trends.

Information contained on this website is general in nature and has been prepared without any consideration of customers’ investment objectives, financial situations or needs. Customers should consider the appropriateness of the information having regard to their personal circumstances before making any investment decisions.

Investment products are not insured by the Federal Deposit Insurance Corporation (FDIC) or guaranteed by a bank, and may decline in value.

The services and products offered on the website are subject to applicable laws and regulations, as well as relevant service terms and policies. The services and products are not available to all customers or in all geographic areas or in any jurisdiction where it is unlawful for us to offer such services and products.

Copyright © 2024 Moomoo Technologies Inc. All Rights Reserved.